The Regulatory Inspection Mindset

You Don’t Pass an FDA Inspection the Week Before. You Pass It Every Day.

There’s a persistent myth in life sciences that inspection readiness is something you achieve right before an audit — a flurry of binder updates, a few mock walkthrough sessions, maybe a late Friday afternoon spent closing out that deviation from Q2.

I’ve spent over a decade helping companies prepare for FDA inspections, and I can tell you: that approach doesn’t work. And more importantly, it doesn’t have to be that way.

FDA Investigators Aren’t Your Enemy

Let’s start here, because the anxiety around inspections often stems from a misunderstanding of what an investigator is actually doing when they walk through your door.

They’re not there to find a reason to shut you down. They’re trained to identify gaps — specifically, gaps between what your documentation says and what your people actually do. That’s it.

When you understand that framing, inspection prep stops feeling like a high-stakes performance and starts feeling like something much more manageable: a consistency check.

What I Tell Teams Before Every Inspection

After helping prepare for dozens of regulatory inspections, the guidance that actually moves the needle isn’t complicated. Here’s what I come back to every time.

Your inspection started months ago.

Every document your team writes today will be read by someone in the future who has zero context about what was happening in that moment — the timeline pressure, the equipment issue, the last-minute personnel change. Write for that person.

Good documentation isn’t about being thorough for its own sake. It’s about telling a complete, accurate story that holds up under scrutiny when you’re not in the room to explain it. If your records require you to be present to interpret them, they aren’t ready for an audit.

Consistency beats perfection.

A simple quality system that your team follows 100% of the time will always outperform a sophisticated one that gets followed 80% of the time. Every single time.

Investigators aren’t just reading your SOPs — they’re comparing those SOPs to your batch records, your deviation logs, your training documentation. They’re looking for the delta. The bigger the delta, the bigger the finding.

Before you add another layer of complexity to your quality system, ask yourself: are you actually executing what you already have?

Your team is your best asset — or your biggest risk.

This is the one that keeps quality leaders up at night, and for good reason.

FDA investigators don’t only interview quality leadership. They talk to operators on the floor. They ask people to walk them through what they do and why. And if your frontline team can execute a procedure but can’t explain the rationale behind it, that gap shows.

Compliance isn’t a QA department function. It’s a culture. Investing in training that goes beyond “here’s what to do” and gets into “here’s why it matters” pays dividends in ways that are hard to quantify until an investigator asks your line operator a question and they answer it confidently.

Have the hard conversations now.

That deviation from six months ago that never got properly closed. The process validation you’ve been putting off because resources are tight. The CAPA that’s been in “investigation” status longer than anyone wants to admit.

These aren’t just administrative headaches. They are the findings waiting to happen.

The closer you get to an inspection without addressing these open items, the harder it becomes to address them at all — because now anything you do looks reactive. Investigators notice that too.

What “Inspection-Ready” Actually Looks Like

Inspection readiness isn’t a state you arrive at. It’s a set of habits your organization maintains continuously.

It looks like deviation investigations that get closed on time, every time — not because an audit is coming, but because that’s the standard. It looks like change control documentation that a new hire could follow from beginning to end without asking for help. It looks like a team that understands compliance not as an overhead burden, but as the foundation that makes everything else possible.

The best thing I can tell any quality team is this: build the habits that make audits routine. When an investigator walks in and your systems are what they’ve always been — documented, followed, and understood — there’s nothing to scramble for.

That’s not an idealized version of quality management. That’s what it looks like when it’s

working.

Azania is the founder of Foundry Quality Group, a quality management consulting practice that helps early-stage life sciences companies build the systems and culture needed to scale confidently through regulatory milestones.